No Link for Maternal Flu Infection, Increased ASD Risk

Share this content:
No Link for Maternal Flu Infection, Increased ASD Risk
No Link for Maternal Flu Infection, Increased ASD Risk

WEDNESDAY, Nov. 30, 2016 (HealthDay News) -- Maternal influenza infection during pregnancy is not associated with increased risk of autism spectrum disorder (ASD), according to a study published online Nov. 28 in JAMA Pediatrics.

Ousseny Zerbo, Ph.D., from Kaiser Permanente Northern California in Oakland, and colleagues examined the correlation between influenza infection and vaccination during pregnancy and ASD risk in a cohort study involving 196,929 children born from Jan. 1, 2000, through Dec. 31, 2010.

The researchers found that influenza was diagnosed in 0.7 percent of mothers, and 23 percent received an influenza vaccination during pregnancy. Overall, 1.6 percent of children were diagnosed with ASD. There was no association for maternal influenza infection (adjusted hazard ratio, 1.04; 95 percent confidence interval, 0.68 to 1.58) or influenza vaccination (adjusted hazard ratio, 1.10; 95 percent confidence interval, 1.00 to 1.21) anytime during pregnancy with increased ASD risk after adjustment for confounding variables. Only first-trimester influenza vaccination correlated with increased ASD risk in trimester-specific analyses (adjusted hazard ratio, 1.20; 95 percent confidence interval, 1.04 to 1.39). If Bonferroni corrected for the multiplicity of hypotheses tested, this correlation could be due to chance (P = 0.1).

"There was no association between maternal influenza infection anytime during pregnancy and increased ASD risk," the authors write. "These findings do not call for changes in vaccine policy or practice, but do suggest the need for additional studies on maternal influenza vaccination and autism."

One author disclosed financial ties to the pharmaceutical industry.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

AAN: Erenumab Shows Promise for Hard-to-Treat Migraine

AAN: Erenumab Shows Promise for Hard-to-Treat Migraine

Higher proportion of patients achieved a ≥50 percent reduction in mean monthly migraine days

AAN: New Drug May Help Infants With Spinal Muscular Atrophy

AAN: New Drug May Help Infants With Spinal ...

RG7916 increases survival motor neuron protein level, with 6.5-fold increase noted with highest dose

Small Link for Cannabis Use, Reduced Cognitive Functioning

Small Link for Cannabis Use, Reduced Cognitive Functioning

Small overall effect size for frequent and heavy cannabis use among adolescents, young adults

is free, fast, and customized just for you!

Already a member?

Sign In Now »